WallStreetZen

NYSE: ABBV
AbbVie Inc Stock Forecast, Predictions & Price Target

Analyst price target for ABBV

Based on 7 analysts offering 12 month price targets for AbbVie Inc.
Min Forecast
$105.00-9.01%
Avg Forecast
$125.29+8.57%
Max Forecast
$144.00+24.78%

Should I buy or sell ABBV stock?

Strong Buy
Strong Buy
3 analysts 42.86%
Buy
4 analysts 57.14%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ABBV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
David Risinger
Morgan Stanley
Strong BuyMaintains$116.00+0.52%2021-01-28
Andrew Baum
Citigroup
Strong BuyMaintains$105.00-9.01%2020-09-02
Steve Chesney
Atlantic Equities
Strong BuyUpgrades$115.00-0.35%2020-06-23
Gary Nachman
BMO Capital
BuyMaintains$129.00+11.79%2021-05-03
Anonymous
SVB Leerink
BuyMaintains$144.00+24.78%2021-03-30
Geoff Porges
SVB Leerink
BuyMaintains$140.00+21.32%2021-02-04
Geoffrey Porges
SVB Leerink
BuyMaintains$128.00+10.92%2020-12-16

1 of 1

Forecast return on equity

Is ABBV forecast to generate an efficient return?
Company
160.2%
Industry
71.23%
Market
61.34%
ABBV's Return on Equity is forecast to be high in 3 years (160.2%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ABBV forecast to generate an efficient return on assets?
Company
14.59%
Industry
16.07%
Market
18.93%
ABBV is forecast to generate lower Return on Assets (14.59%) than the US Drug Manufacturers - General industry average (16.07%)
Forecast

ABBV earnings per share forecast

What is ABBV's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$12.60+351.61%
Avg 2 year Forecast
$14.00+401.61%
Avg 3 year Forecast
$12.09+333.41%
ABBV's earnings are forecast to grow at an exceptional rate of 66.56% per year
Forecast

ABBV revenue forecast

What is ABBV's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$55.9B+11.43%
Avg 2 year Forecast
$59.8B+19.23%
Avg 3 year Forecast
$56.4B+12.28%
ABBV's revenue is forecast to grow at a rate of 4.69% per year, which is not exceptional
Forecast

ABBV earnings growth forecast

How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
66.56%
Industry
29.85%
Market
19.57%
ABBV's earnings are forecast to grow faster (66.56% per year) than the US Drug Manufacturers - General industry average (29.85%)
Forecast
ABBV's earnings are forecast to grow faster (66.56% per year) than the US market average (19.57%)
Forecast
ABBV's earnings are forecast to grow faster (66.56% per year) than the risk-free savings rate (1.5%)
Forecast

ABBV revenue growth forecast

How is ABBV forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
4.69%
Industry
5.33%
Market
14.55%
ABBV's revenues are forecast to grow slower (4.69% per year) than the US Drug Manufacturers - General industry average (5.33%)
Forecast
ABBV's revenues are forecast to grow slower (4.69% per year) than the US market average (14.55%)
Forecast

AbbVie Stock Forecast FAQ

Is AbbVie Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock.

Out of 7 analysts, 3 (42.86%) are recommending ABBV as a Strong Buy, 4 (57.14%) are recommending ABBV as a Buy, 0 (0%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell.

What is ABBV's earnings growth forecast for 2021-2023?

(NYSE: ABBV) AbbVie's forecast annual earnings growth rate of 66.56% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 29.85%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 19.57%.

AbbVie's earnings in 2021 is $5,159,000,000.On average, 8 Wall Street analysts forecast ABBV's earnings for 2021 to be $22,254,401,434, with the lowest ABBV earnings forecast at $22,077,779,200, and the highest ABBV earnings forecast at $22,907,903,698. On average, 8 Wall Street analysts forecast ABBV's earnings for 2022 to be $24,718,281,592, with the lowest ABBV earnings forecast at $24,002,961,546, and the highest ABBV earnings forecast at $25,875,157,222.

In 2023, ABBV is forecast to generate $21,357,160,487 in earnings, with the lowest earnings forecast at $19,958,312,397 and the highest earnings forecast at $22,395,699,220.

What is ABBV's revenue growth forecast for 2021-2023?

(NYSE: ABBV) AbbVie's forecast annual revenue growth rate of 4.69% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.55%.

AbbVie's revenue in 2021 is $50,195,000,000.On average, 5 Wall Street analysts forecast ABBV's revenue for 2021 to be $98,792,240,451,181, with the lowest ABBV revenue forecast at $98,659,413,466,624, and the highest ABBV revenue forecast at $99,026,081,223,578. On average, 5 Wall Street analysts forecast ABBV's revenue for 2022 to be $105,706,206,096,569, with the lowest ABBV revenue forecast at $103,696,679,568,896, and the highest ABBV revenue forecast at $107,786,720,632,371.

In 2023, ABBV is forecast to generate $99,540,362,778,485 in revenue, with the lowest revenue forecast at $97,198,747,594,752 and the highest revenue forecast at $101,760,493,657,503.

What is ABBV's forecast return on assets (ROA) for 2021-2024?

(NYSE: ABBV) forecast ROA is 14.59%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.07%.

What is ABBV's Price Target?

According to 7 Wall Street analysts that have issued a 1 year ABBV price target, the average ABBV price target is $125.29, with the highest ABBV stock price forecast at $144.00 and the lowest ABBV stock price forecast at $105.00.

On average, Wall Street analysts predict that AbbVie's share price could stay at $125.29 by May 3, 2022. The average AbbVie stock price prediction forecasts a potential downside of N/A from the current ABBV share price of $115.40.

What is ABBV's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ABBV) AbbVie's current Earnings Per Share (EPS) is $2.79. On average, analysts forecast that ABBV's EPS will be $12.60 for 2021, with the lowest EPS forecast at $12.50, and the highest EPS forecast at $12.97. On average, analysts forecast that ABBV's EPS will be $14.00 for 2022, with the lowest EPS forecast at $13.59, and the highest EPS forecast at $14.65. In 2023, ABBV's EPS is forecast to hit $12.09 (min: $11.30, max: $12.68).

What is ABBV's forecast return on equity (ROE) for 2021-2024?

(NYSE: ABBV) forecast ROE is 160.2%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.